Gene Biotherapeutics, Inc. (CRXM)

USD 0.0

(9900.0%)

Revenue Summary of Gene Biotherapeutics, Inc.

  • Gene Biotherapeutics, Inc.'s latest annual revenue in 2022 was - USD , down 0.0% from previous year.
  • Gene Biotherapeutics, Inc.'s latest quarterly revenue in 2022 FY was - USD , down 0.0% from previous quarter.
  • Gene Biotherapeutics, Inc. reported a annual revenue of - USD in annual revenue 2021, down 0.0% from previous year.
  • Gene Biotherapeutics, Inc. reported a annual revenue of - USD in annual revenue 2020, down 0.0% from previous year.
  • Gene Biotherapeutics, Inc. reported a quarterly revenue of - USD for 2021 FY, down 0.0% from previous quarter.
  • Gene Biotherapeutics, Inc. reported a quarterly revenue of - USD for 2020 Q1, down 0.0% from previous quarter.

Annual Revenue Chart of Gene Biotherapeutics, Inc. (2022 - 1995)

Historical Annual Revenue of Gene Biotherapeutics, Inc. (2022 - 1995)

Year Revenue Revenue Growth
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD -100.0%
2013 109.2 Thousand USD -86.09%
2012 785.31 Thousand USD 0.0%
2011 - USD -100.0%
2010 244.47 Thousand USD -45.05%
2009 444.94 Thousand USD -81.59%
2008 2.41 Million USD 52.37%
2007 1.58 Million USD 109.82%
2006 756.13 Thousand USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%
2001 - USD 0.0%
2000 - USD 0.0%
1999 - USD -100.0%
1998 4.55 Million USD 34.26%
1997 3.39 Million USD 438.03%
1996 630.48 Thousand USD 64.98%
1995 382.15 Thousand USD 0.0%

Peer Revenue Comparison of Gene Biotherapeutics, Inc.

Name Revenue Revenue Difference
America Great Health 204.3 Thousand USD 100.0%
Ampio Pharmaceuticals, Inc. - USD NaN%
Aridis Pharmaceuticals, Inc. - USD NaN%
Biora Therapeutics, Inc. 4000.00 USD 100.0%
Bio-Path Holdings, Inc. - USD NaN%
Better Therapeutics, Inc. - USD NaN%
Calithera Biosciences, Inc. - USD NaN%
Comera Life Sciences Holdings, Inc. 633.1 Thousand USD 100.0%
eFFECTOR Therapeutics, Inc. - USD NaN%
Eloxx Pharmaceuticals, Inc. - USD NaN%
Evelo Biosciences, Inc. - USD NaN%
Evolutionary Genomics, Inc. - USD NaN%
Finch Therapeutics Group, Inc. 107 Thousand USD 100.0%
Galera Therapeutics, Inc. - USD NaN%
Innovation1 Biotech Inc. - USD NaN%
Kiromic BioPharma, Inc. - USD NaN%
Molecular Templates, Inc. 57.3 Million USD 100.0%
Navidea Biopharmaceuticals, Inc. 65.65 Thousand USD 100.0%
NexImmune, Inc. - USD NaN%
Orgenesis Inc. 530 Thousand USD 100.0%
Panbela Therapeutics, Inc. - USD NaN%
Point of Care Nano-Technology, Inc. - USD NaN%
PaxMedica, Inc. Common Stock - USD NaN%
Scopus BioPharma Inc. - USD NaN%
Sorrento Therapeutics, Inc. 62.83 Million USD 100.0%
Statera Biopharma, Inc. - USD NaN%
TRACON Pharmaceuticals, Inc. 12.04 Million USD 100.0%
Trevena, Inc. 3.12 Million USD 100.0%
Vaxxinity, Inc. - USD NaN%
Vaccinex, Inc. 570 Thousand USD 100.0%
Vicapsys Life Sciences, Inc. - USD NaN%
Viracta Therapeutics, Inc. - USD NaN%
ZIVO Bioscience, Inc. 27.65 Thousand USD 100.0%